Management of advanced stages of Osteonecrosis of the Jaws due to Bisphosphonates: Report of two cases

Authors

  • Amminou Loubna Dental Center of treatment and Diagnosis (Ibn Sina Hospital),Rabat, Morocco
  • Chbicheb Saliha Faculty of Dentistry of Rabat, Mohammed V University Morocco
  • El Wady Wafaa Faculty of Dentistry of Rabat, Mohammed V University,Morocco

DOI:

https://doi.org/10.21276/apjhs.2017.4.3.1

Keywords:

Bisphosphonates, Multiple myeloma, Breast cancer, Osteonecrosis, Jaws

Abstract

Bisphosphonates are a class of drugs used to strengthen bone. They are indicated in the treatment of osteoporosis and Paget's disease as well as malignant pathologies such as breast cancer, bone metastases. The examples of medications bisphosphonates includes Aledronate, Ibandronate, Incadronate, Olpadronate, Pamidronate, Risedronate, and Zoledronate. One of the most important complications of bisphosphonates is osteonecrosis of the jaws which alters the quality of life of the patient and is all the more difficult to manage as osteonecrosis is advanced. This paper describes two cases of advanced osteonecrosis whose management was very difficult leading to a recurrence of this complication.

Downloads

Download data is not yet available.

Author Biographies

Amminou Loubna, Dental Center of treatment and Diagnosis (Ibn Sina Hospital),Rabat, Morocco

Resident in the department of oral surgery

Chbicheb Saliha, Faculty of Dentistry of Rabat, Mohammed V University Morocco

Professor of oral surgery

El Wady Wafaa, Faculty of Dentistry of Rabat, Mohammed V University,Morocco

Professor and head of the oral surgery service

Downloads

Published

2017-09-30

How to Cite

Amminou Loubna, Chbicheb Saliha, & El Wady Wafaa. (2017). Management of advanced stages of Osteonecrosis of the Jaws due to Bisphosphonates: Report of two cases. Asian Pacific Journal of Health Sciences, 4(3), 1–5. https://doi.org/10.21276/apjhs.2017.4.3.1

Issue

Vol. 4 No. 3 (2017): Vol 4 | Issue 3 | July - September 2017

Section

Table of Contents

License

Asian Pacific Journal of Health Sciences applies the Creative Commons Attribution (CC-BY) license to published articles. Under this license, authors retain ownership of the copyright for their content, but they allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. Appropriate attribution can be provided by simply citing the original article.